Japan Drug Imports Exceeds ¥1 Trillion, Trade Deficit at ¥700 Billion
This article was originally published in PharmAsia News
Japan's trade data for 2007, released by the Department of Treasury, shows that the country's import of drugs increased by 8.8 percent to ¥1.078 trillion. EU was the biggest exporter, sending ¥634.4 billion worth of drugs to Japan and followed by the U.S., ¥168.3 billion. Import from China jumped 33.1 percent to ¥46.9 billion. Japan exported ¥374.4 billion worth of drugs in 2007, a 0.6 percent increase. The biggest importer of Japanese drugs was the U.S., with a total of ¥127 billion, and followed by EU, ¥119 billion. Japan's export to China was ¥22.7 billion. (Click here for more - Japanese language
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.